1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. INCYTE CORP.
Incyte Corp. XNAS: INCY

Incyte Corp. Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Incyte focuses on the discovery and development of small-molecule drugs. The firm's leading drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheuma...

Read More
86.39 0.95 (1.11%)
New 52W High in past week
706.1K
XNAS Volume

XNAS 05 Sep, 2025 3:06 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Incyte Corp. is on 09 Sep 2025 for the purpose of Morgan Stanley Global Healthcare Conference See details
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
47.5 / 100
Momentum Score
Technically Neutral
58.9 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
82
1Yr Price target downside is -5%
23 analysts

20

S

3

W

1

O

2

T

SWOT Analysis

Incyte Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..